Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome

Journal of Pediatrics

Volumn 137, Issue 1, 2000, Pages 42-49

  Myers, Susan E ^a,b   Carrel, Aaron L ^a,b   Whitman, Barbara Y ^a,b   Allen, David B ^a,b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b University of Wisconsin Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; HUMAN GROWTH HORMONE; LIPID;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MINERAL; CARBOHYDRATE METABOLISM; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ENERGY EXPENDITURE; FEMALE; GROWTH INHIBITION; HORMONAL THERAPY; HUMAN; LEAN BODY WEIGHT; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCOLIOSIS; STRENGTH; THYROID FUNCTION;

EID: 0034234356     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.105369     Document Type: Article

References (29)

1. Prader, A, Labhart, A, Willi, H1956Ein syndrom von adipositas, kleinwuchs, kryptochismus and oligophrenie.Schweiz Med Wochenschr.
2. Holm V.A., Cassidy S.B., Butler M.G., Hanchett J.M., Greenswag L.R., Whitman B.Y. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 91:1993;398-402.
3. Ledbetter D.H., Riccardi V.M., Airhart S.D., Strobel R.J., Keenen S.B., Crawford J.D. Deletion of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med. 304:1981;325-329.
4. Nicholls, RD, Knoll, JHM, Butler, MG, Karam, S, Lalande, M1989Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome.Nature (London).
5. Whitman, BY, 1998, Prader-Willi syndrome: facts regarding prevalence rates. Prader-Willi Syndrome Association, USA, Position Statement
6. Schoeller D.A., Levitsky L.L., Bandini L.G., Dietz W.W., Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism. 37:1988;115-120.
7. Brambilla, P, Bosio, L, Manzoni, P, Pietrobelli, A, Beccaria, L, Chiumello, G1997Peculiar body composition in patients with Prader-Labhart-Willi syndrome.Am J Clin Nutr.
8. Beshyah, SA, Freemantle, C, Thomas, E1995Comparison of body composition by dual-energy x-ray absorptiometry before and during growth hormone treatment.Am J Clin Nutr.
9. Bray G.A., Dahms W.T., Swerdloff R.S., Fiser R.H., Atkinson R.L., Carrel R.E. The Prader Willi syndrome: a study of 40 patients and review of the literature. Medicine. 62:1983;59-80.
10. Costeff H., Holm V.A., Ruvalcaba R., Shaver J. Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand. 79:1990;1059-1062.
11. Lee P.D.K. Endocrine and metabolic aspects of Prader-Willi syndrome. Management of Prader-Willi Syndrome. 2nd ed. New York: Springer-Verlag. 1995;32-57.
12. Cuneo R.C., Judd S., Wallace J.D., Keene D., Burger H., Tio S. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 83:1998;107-116.
13. Lee P.D.K., Wilson D.M., Hintz R.L., Rosenfeld R.G. Growth hormone treatment of short stature in Prader-Willi syndrome. J Pediatr Endocrinol. 2:1987;31-34.
14. Eiholzer, U, Gisin, R, Weinmann, C, Kreimler, S, Steinert, H, Torresani, T1998Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance.Eur J Pediatr.
15. Lee, PDK, Hwu, K, Henson, H, Brown, BT, Bricker, JT, LeBlanc, AD1993Body composition studies in Prader-Willi syndrome: effects of growth hormone therapy.Basic Life Sci.
16. Lindgren A.C., Hagenas L., Muller J., Blichfeldt S., Rosenborg M., Brismar M. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr. 87:1998;28-31.
17. Carrel A.L., Myers S.E., Whitman B.Y., Allen D.B. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr. 134:1999;215-221.
18. Angulo, M, Margana, M, Mazur, B, Canas, JA, Vitollo, PM, Sarrantonio, M1996Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.J Pediatr Endocrinol Metab.
19. Carrel A.L., Huber S., Allen D.B., Voelkerding K.V. Assessment of SNPRN expression as a molecular tool in the diagnosis of Prader-Willi syndrome. Molecular Diagnosis. 4:1999;1.
20. Hall, JG, Iskenius, UG, Allanson, JE1989Handbook of normal physical measurements.Oxford: Oxford Medical Publications, Oxford University Press;
21. Fleisch A. Le metabolisme basal standard et sa determination au mogen du Metabolcalculator. Helv Med Acta. 18:1951;23-44.
22. Bruininks, RH, 1978, Bruininks-Oseretsky test of motor proficiency. Circle Pines, MN: American Guidance Service;
23. Guo, SS, Chumlea, WC, Roche, AF, Siervogel, RM1997Age- and maturity-related changes in body composition during adolescence into adulthood: The Fels Longitudinal Study.Int J Obes Relat Metab Disord.
24. Williams T., Berelowitz M., Joffe S.N., Thorner M.O., Rivier J., Vale W. Impaired growth hormone response to growth-hormone releasing factor in obesity. N Engl J Med. 311:1984;1403-1407.
25. Dieguez C., Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol (Oxf). 28:1988;109-143.
26. Dieguez C., Casanueva F.F. Influence of metabolic substrates and obesity on growth hormone secretion. Trends Endocrinol Metab. 1995;55-59.
27. Hauffa, BP, 1997, One year results of growth hormone treatment of short stature in Prader-Willi syndrome. Acta Paediatr Scand.
28. Bell J.J., Dana K. Lack of correlation between growth hormone provocative test results and subsequent growth rates during growth hormone therapy. Pediatrics. 102:1998;518-520.
29. Butler, MG, Hovis, CL, Angulo, MA1998Photoanthropometric study of craniofacial traits in individuals with Prader-Willi syndrome on short-term growth hormone therapy.Clin Genet.